Fundraising Fox

Florian Denis

Investor

Investor at Elaia

Paris, France

Writes $100K – $5M checks · typically $1.5M

About

Florian Denis is a scientifically conversant investor—serving on HEPHAISTOS‑Pharma’s board, offering mechanism-level immunology and clinical strategy guidance, and applying a repeatable early-stage-to-acquisition playbook proven by Gleamer and Mablink exits.

Invests in

AI & Machine LearningBiotechCleantechCybersecurityDeep TechHardwareHealthtechMedical DevicesSaaS

Experience

  1. ElaiaPartnercurrent2025 — presentParis, Île-de-France, France
  2. ElaiaInvestment Director2021 — 2025Paris, Île-de-France, France
  3. ElaiaInvestment Manager2019 — 2021Greater Paris Metropolitan Region
  4. BIOPHTABoard Membercurrent2024 — present
  5. HEPHAISTOS-PharmaBoard Membercurrent2024 — present
  6. GLEAMERBoard Membercurrent2021 — presentParis, Île-de-France, France
  7. Mablink BioscienceBoard Member2021 — 2023Lyon, Auvergne-Rhône-Alpes, France
  8. Société de Bourse Gilbert DupontEquity Research Analyst2019Greater Paris Metropolitan Region
  9. VitaDXSupervisory Board Member2017 — 2019Paris, Île-de-France, France
  10. TheranexusBoard Member2017 — 2019
  11. AurigaLife Sciences Associate2015 — 2019Paris, Île-de-France, France

Education

  1. Université Paris Dauphine - PSLMaster of Science (M.Sc.), Management de la Technologie et de l'Innovation (MTI)2013 — 2014
  2. SupBiotech, école de biotechnologiesMaster's degree, Biotechnology2009 — 2014
  3. University of Essex2011 — 2012

Skills & more

Biotechnology16Lifesciences9Competitive Intelligence6CK theory3Innovation Management5Business Development8Life Sciences5

Languages English

From Florian's professional profile.

Same school

Shared employers

Colleagues at Elaia

Network4

Investors connected to Florian in public investor directories — a warm-intro map.